These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 33615736)

  • 1. Strategies towards Targeting Gαi/s Proteins: Scanning of Protein-Protein Interaction Sites To Overcome Inaccessibility.
    Nubbemeyer B; Pepanian A; Paul George AA; Imhof D
    ChemMedChem; 2021 Jun; 16(11):1696-1715. PubMed ID: 33615736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of inhibitors of heterotrimeric Gαi subunits.
    Appleton KM; Bigham KJ; Lindsey CC; Hazard S; Lirjoni J; Parnham S; Hennig M; Peterson YK
    Bioorg Med Chem; 2014 Jul; 22(13):3423-34. PubMed ID: 24818958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scanning Protein Surfaces with DNA-Encoded Libraries.
    Kunig VBK; Potowski M; Klika Škopić M; Brunschweiger A
    ChemMedChem; 2021 Apr; 16(7):1048-1062. PubMed ID: 33295694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PAR4-derived pepducin P4Pal
    Holdfeldt A; Lind S; Hesse C; Dahlgren C; Forsman H
    Biochem Pharmacol; 2020 Oct; 180():114143. PubMed ID: 32653592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the α-subunits of heterotrimeric G-proteins with GPCRs, effectors and RGS proteins: a critical review and analysis of interacting surfaces, conformational shifts, structural diversity and electrostatic potentials.
    Baltoumas FA; Theodoropoulou MC; Hamodrakas SJ
    J Struct Biol; 2013 Jun; 182(3):209-18. PubMed ID: 23523730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydromunduletone Is a Small-Molecule Selective Adhesion G Protein-Coupled Receptor Antagonist.
    Stoveken HM; Bahr LL; Anders MW; Wojtovich AP; Smrcka AV; Tall GG
    Mol Pharmacol; 2016 Sep; 90(3):214-24. PubMed ID: 27338081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncanonical scaffolding of G
    Smith JS; Pack TF; Inoue A; Lee C; Zheng K; Choi I; Eiger DS; Warman A; Xiong X; Ma Z; Viswanathan G; Levitan IM; Rochelle LK; Staus DP; Snyder JC; Kahsai AW; Caron MG; Rajagopal S
    Science; 2021 Mar; 371(6534):. PubMed ID: 33479120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thematic Minireview Series: New Directions in G Protein-coupled Receptor Pharmacology.
    Dohlman HG
    J Biol Chem; 2015 Aug; 290(32):19469-70. PubMed ID: 26126823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Gαi knock-out HEK293 cells illuminates Gαi-coupling diversity of GPCRs.
    Ono Y; Kawakami K; Nakamura G; Ishida S; Aoki J; Inoue A
    Commun Biol; 2023 Jan; 6(1):112. PubMed ID: 36709222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular Receptor Modulation: Novel Approach to Target GPCRs.
    Ortiz Zacarías NV; Lenselink EB; IJzerman AP; Handel TM; Heitman LH
    Trends Pharmacol Sci; 2018 Jun; 39(6):547-559. PubMed ID: 29653834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [
    Diez-Alarcia R; Yáñez-Pérez V; Muneta-Arrate I; Arrasate S; Lete E; Meana JJ; González-Díaz H
    ACS Chem Neurosci; 2019 Nov; 10(11):4476-4491. PubMed ID: 31618004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances of Small Molecular Regulators Targeting G Protein- Coupled Receptors Family for Oncology Immunotherapy.
    He P; Zhou W; Liu M; Chen Y
    Curr Top Med Chem; 2019; 19(16):1464-1483. PubMed ID: 31264549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of cysteine exposure and global protein dynamics in small-molecule recognition by a regulator of G-protein signaling protein.
    Mohammadi M; Mohammadiarani H; Shaw VS; Neubig RR; Vashisth H
    Proteins; 2019 Feb; 87(2):146-156. PubMed ID: 30521141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gαi-GIV binding interface is a druggable protein-protein interaction.
    DiGiacomo V; de Opakua AI; Papakonstantinou MP; Nguyen LT; Merino N; Blanco-Canosa JB; Blanco FJ; Garcia-Marcos M
    Sci Rep; 2017 Aug; 7(1):8575. PubMed ID: 28819150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G protein database, GproteinDb.
    Pándy-Szekeres G; Esguerra M; Hauser AS; Caroli J; Munk C; Pilger S; Keserű GM; Kooistra AJ; Gloriam DE
    Nucleic Acids Res; 2022 Jan; 50(D1):D518-D525. PubMed ID: 34570219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.